Ilika plc Grant of Fuel Cell Catalyst Patents in USA

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology and materials innovation, announced today the grant of three patents covering catalysts for hydrogen fuel cells in the USA. These patents cover a type of catalyst known as “Core-Shell Catalysts”, where the catalyst is the coating on nano-scale spherical particles, like the hard shell on a golf ball.

Catalysts are key to ensuring the efficiency and reliability of fuel cells. The catalysts must therefore be stable in the aggressive acidic environment created within hydrogen fuel cells, whilst highly active in promoting the chemical reactions necessary for converting hydrogen and oxygen into electricity and water.

Core-Shell Nanostructured Catalysts typically have a relatively low-cost and stable core, which is then coated with a thin layer (shell) of the active catalyst. The Company’s patented catalysts have mixed metal oxide (ceramic) cores covered in platinum. The three wholly owned granted patents were originally filed in January 2013. The Company had previously undertaken a joint development project with Toyota examining other catalyst materials which resulted in an earlier jointly-owned patent filing, which has since gone to grant in Japan and is currently being processed in other jurisdictions.

Commenting on the patents granted, Graeme Purdy, Ilika Plc CEO, said: “Whilst our solid-state battery programme is our key focus, our materials discovery platform is generating innovative, patentable materials with a variety of applications. The pace of innovation in the automotive industry has never been greater as companies compete to develop increasingly more energy-efficient, low emission vehicles. While electrical hybrid vehicles using battery technology have captured the largest share of the low-emission market at this point and fully battery-powered electric vehicles are also seeing strong take-up, fuel cell vehicles offer the advantage of long driving range, which justifies the development of key technologies such as low-cost, robust catalysts.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search